EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer
Dubsky, P., Filipits, M., Jakesz, R., Rudas, M., Singer, C.F., Greil, R., Dietze, O., Luisser, I., Klug, E., Sedivy, R., Bachner, M., Mayr, D., Schmidt, M., Gehrmann, M.C., Petry, C., Weber, K.E., Kronenwett, R., Brase, J.C., Gnant, M.
Published in Annals of oncology (01.03.2013)
Published in Annals of oncology (01.03.2013)
Get full text
Journal Article
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients
DUBSKY, P, BRASE, J. C, BACHNER, M, MAYR, D, SCHMIDT, M, GEHRMANN, M. C, PETRY, C, WEBER, K. E, FISCH, K, KRONENWETT, R, GNANT, M, FILIPITS, M, JAKESZ, R, RUDAS, M, SINGER, C. F, GREIL, R, DIETZE, O, LUISSER, I, KLUG, E, SEDIVY, R
Published in British journal of cancer (10.12.2013)
Published in British journal of cancer (10.12.2013)
Get full text
Journal Article
Abstract P3-03-24: ABCSG 33 - A multi center registry to evaluate the affect of macro metastasis in sentinel lymph node on survival
Strobl, SA, Dubsky, P, Exner, R, Gnant, M, Jakesz, R, Tausch, C, Wette, V, Heck, D, Luisser, I, Bjelic-Radisic, V, Schrenk, P, Poyssl, C, Mathis, J, Fitzal, F
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article